Royal Healthcare in Singapore provides NEC's "FonesVisuas Test" for Disease Risk Prediction
TOKYO, March 26, 2026 /PRNewswire/ -- NEC Corporation (NEC; TSE: 6701) announced that its FonesVisuas Test, an innovative blood test that predicts disease risk, is being offered by Royal Healthcare (*1), a Singapore-based medical institution and...